Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group

The persistence and recurrence of choroidal neovascularization after initial treatment with laser photocoagulation have been shown to be major contributors to loss of visual acuity. The 247 eyes assigned to krypton red laser photocoagulation in the Age-Related Macular Degeneration Study-Krypton Laser were examined to describe the incidence, timing, visual impact, and potential risk factors for persistence and recurrence. Persistent neovascularization detected within 6 weeks of initial treatment was observed in 32% of treated eyes, and recurrent neovascularization was estimated by life-table methods to develop in an additional 47% over a 5-year period. Both persistence and recurrence were accompanied by an increased frequency of severe visual loss. The persistence rate among eyes having 10% or more of the foveal side of the neovascular membrane not covered by treatment was twice as high as in eyes having more extensive coverage. Patients having a fellow eye with a neovascular membrane or scar, a fellow eye with 20 or more drusen in the central macula, or a fellow eye with nongeographic atrophy at initial visit had more recurrences than patients without these characteristics. Ophthalmologists treating similar lesions may be able to reduce persistent neovascularization and the associated visual loss by covering the entire lesion with treatment.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nonhuman Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Overexpression of Vascular Endothelial Growth Factor
Lebherz et al.
Diabetes 2005;54:1141-1149.
ABSTRACT | FULL TEXT  

Retinal Pigment Epithelium Wound Healing in Human Bruch's Membrane Explants
Wang et al.
IOVS 2003;44:2199-2210.
ABSTRACT | FULL TEXT  

Short-Term Study of Allogeneic Retinal Pigment Epithelium Transplants onto Debrided Bruch's Membrane
Wang et al.
IOVS 2001;42:2990-2999.
ABSTRACT | FULL TEXT  

Monoclonal Antibody-Mediated Drug Targeting to Choroidal Neovascularization in the Rat
Kamizuru et al.
IOVS 2001;42:2664-2672.
ABSTRACT | FULL TEXT  

Age-Related Maculopathy in a Randomized Trial of Low-Dose Aspirin Among US Physicians
Christen et al.
Arch Ophthalmol 2001;119:1143-1149.
ABSTRACT | FULL TEXT  

The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants--Age-Related Eye Disease Study Report No. 2
Group
J. Nutr. 2000;130:1516S-1519.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study
Miller et al.
Arch Ophthalmol 1999;117:1161-1173.
ABSTRACT | FULL TEXT  

Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study
Donati et al.
Br. J. Ophthalmol. 1999;83:646-651.
ABSTRACT | FULL TEXT  

Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration
Nasir et al.
Br. J. Ophthalmol. 1997;81:481-489.
ABSTRACT | FULL TEXT